Family Med Journals

Family Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Romerius P et al. – Pediatric cancer treatment may imply an increased risk of hypogonadism, leading to metabolic disorders and osteoporosis. Such complications are potentially preventable. Adult male survivors of childhood cancer are at risk of hypogonadism, which should be acknowledged in the long–term follow–up of these men.

Related Articles

Hypogonadism Risk in Men Treated for Childhood Cancer
Internet Source, 11/05/09    Relevance Score: 90%

Hypogonadism in men with erectile dysfunction may be related to a host of chronic illnesses
International Journal of Impotence Research, 10/02/09    Relevance Score: 83%

Outcome of gonadotropin therapy for male infertility due to hypogonadotrophic hypogonadism
Pituitary, 10/29/09    Relevance Score: 82%

Impaired Fibroblast Growth Factor Receptor 1 Signaling as a Cause of Normosmic Idiopathic Hypogonadotropic Hypogonadism
Journal of Clinical Endocrinology and Metabolism, 10/15/09    Relevance Score: 82%

Safety and efficacy of testosterone gel in the treatment of male hypogonadism
Clinical Interventions in Aging, 10/12/09    Relevance Score: 80%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address